[Prognostic factors in stomach carcinoma]

Area of Science:

• Oncology
• Molecular Pathology
• Cancer Prognostics

Context:

• The pTNM staging system is the standard for classifying cancer severity and guiding treatment.
• Identifying novel prognostic markers is essential for improving patient stratification and personalized medicine in gastric cancer.
• Previous studies have explored various molecular markers, but their independent prognostic value requires further validation.

Purpose:

• To investigate the independent prognostic significance of vascular invasion and E-cadherin expression in gastric cancer.
• To determine if these factors can refine patient survival predictions, particularly in pTNM-stage II cases.
• To highlight the need for integrating new molecular and non-molecular markers into future prognostic models.

Summary:

• Classical prognostic factors in the pTNM system remain highly valid for gastric cancer.
• Vascular invasion and the molecular marker E-cadherin have emerged as independent prognostic factors significantly influencing patient survival.
• A notable decrease in survival was observed in pTNM-stage II patients with both absent E-cadherin expression and vascular invasion compared to those with E-cadherin expression and no vascular invasion.

Impact:

• These findings underscore the importance of evaluating vascular invasion and E-cadherin status for more precise gastric cancer prognostication.
• The results suggest that incorporating these markers could lead to more individualized treatment strategies and improved patient management.
• Further research into novel molecular and non-molecular markers is warranted to enhance the prediction of gastric cancer patient outcomes.